Evidence map›Paper›PMID 42467001›Full record

ArticleBioinformatics (Oxford, England)2026

Momentum contrast-enhanced multimodal representation learning for drug synergy prediction.

Yu Gu, Xindi Huang, Lifen Shi, Leying Chen, Guihua Duan, Cheng Yan

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu GuSchool of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China.
Xindi HuangSchool of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China.
Lifen ShiSchool of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China.
Leying ChenSchool of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China.
Guihua DuanSchool of Computer Science and Engineering, Central South University, Changsha 410083, China.
Cheng YanSchool of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China.ORCID 0000-0002-5021-6841

Funding

Education Department of Hunan Province of China 22B0372National Natural Science Foundation of China 62473149National Natural Science Foundation of China 62572488Natural Science Foundation of Hunan Province, China 2022JJ30428
6 · The paper itself

Abstract

motivationAccurate prediction of synergistic drug combinations can accelerate anticancer combination discovery. Existing methods inadequately model higher order drug-drug-cell-line interactions and drug-disease associations and remain sensitive to sparse and noisy multiomics data, limiting generalization to unseen cell lines and drug combinations.

resultsWe present Momentum Contrast (MoCo)-MultiSynergy, a multimodal framework that combines modality-specific momentum contrastive learning with heterogeneous hypergraph modeling. The hypergraph represents synergistic drug-drug-cell-line triplets and drug-disease associations, while gated residual propagation refines node representations. MoCo modules regularize encoded drug and cell-line representations using latent feature masking and Gaussian perturbation. On the O'Neil and NCI-ALMANAC datasets, MoCo-MultiSynergy achieves the highest AUROC and AUPRC across the evaluated settings, with the largest gains when generalizing to unseen cell lines and drug combinations. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/27167199/MoCo-MultiSynergy.

Indexed as

Antineoplastic AgentsComputational BiologyDrug SynergismAlgorithmsCell Line, TumorHumansRepresentation Machine LearningAntineoplastic Agents

Identifiers

PMID42467001
PMCPMC13433264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.